CENTOGENE is proud to contribute to the Face2Gene 60 Day Challenge. This initiative by FDNA was started November 1, 2016. The 60 Day Challenge is a call to clinicians to use Face2Gene to help analyze every patient they see during the next 2 months and thus help the genetics community by improving Face2Gene's learning database, especially in rare disease setting. As a bonus, clinicians will receive genetic testing vouchers - CENTOGENE contributes one whole genome sequencing analysis including detailed medical report (CentoGenome® trio).
Face2Gene is "a suite of phenotyping apps that facilitate comprehensive and precise genetic evaluations". Learn more about Face2 Gene 60 Day challenge here.